{"product_id":"clinical-case-study-joseph-r","title":"CLINICAL CASE STUDY: JOSEPH R.","description":"\u003cp\u003eThe posttransplant administration of cyclophosphamide to prevent both graft-vs-host and hostvs-graft alloreactivity has revolutionized the practice of hematopoietic cell transplantation (HCT). The eligibility boundaries for consideration of HCT have expanded, and now include patients with a suitable haploidentical donor, instead of an HLA-identical sibling donor. This case study provides not only a simulation of treatment choices for a patient with multiple myeloma and end-stage renal disease, but also the background science that is helpful in understanding the clinical situation. AABB thanks Thomas Spitzer, MD, for development of this case study.\u003c\/p\u003e","brand":"Hematology","offers":[{"title":"Default Title","offer_id":48959170838702,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0765\/8179\/8062\/files\/Untitled-15.jpg?v=1787947633","url":"https:\/\/ebooksmedical.com\/products\/clinical-case-study-joseph-r","provider":"Ebooks Medical","version":"1.0","type":"link"}